Evaluasi Penggunaan Obat Antihiperlipidemia Pada Pasien Dislipidemia Di Instalasi Farmasi Rawat Jalan BPJS RS “X” Kota Bekasi Periode Januari – Desember 2023
DOI:
https://doi.org/10.31004/joecy.v6i1.6760Keywords:
dyslipidemia, antihyperlipidemic, statin, medication use evaluation, therapeutic rationalityAbstract
Dyslipidemia is one of the non-communicable diseases that significantly contributes to an increased risk of cardiovascular disease. This condition is characterized by elevated levels of total cholesterol, Low Density Lipoprotein (LDL), triglycerides (TG), and reduced levels of High Density Lipoprotein (HDL). The study purpose was to evaluate the appropriateness of antihyperlipidemic drug use in dyslipidemia patients at the Outpatient Pharmacy Department of BPJS Hospital X in Bekasi City.
Materials and methods a descriptive method with a purposive sampling approach.
Results Out of 54 patients studied, statin-class medications were the most commonly prescribed (79.63%), consisting of Simvastatin and Atorvastatin, each accounting for 38.89%. The evaluation of medication appropriateness showed 94.44% appropriateness for patients, 92.59% appropriateness in medication selection, and 90.74% appropriateness in dosage.
Conclusions These results indicate that the use of antihyperlipidemic medications at the Outpatient Pharmacy Unit of Hospital X largely aligns with rational criteria.
References
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., John Chapman, M., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., Reiner, Ž., Riccardi, G., Taskinen, M. R., Tokgozoglu, L., Monique Verschuren, W. M., Vlachopoulos, C., Wood, D. A., Zamorano, J. L., Badimon, L., … Wald, D. (2016). ESC/EAS Guidelines for the Management of Dyslipidaemias. In European Heart Journal (Vol. 37, Issue 39, pp. 2999–3058l). Oxford University Press. https://doi.org/10.1093/eurheartj/ehw272
Dart, A., Jerums, G., Nicholson, G., D’emden, M., Hamilton-Craig, I., Tallis, G., Best, J., West, M., Sullivan, D., Brats, P., & Black, D. (1997). A Multicenter, Double-Blind, One-Year Study Comparing Safety and Efficacy of Atorvastatin Versus Simvastatin in Patients With Hypercholesterolemia. The American Journal Of Cardiology, 80. https://doi.org/10.1016/s0002-9149(97)00280-4
Dixon L Dave, R. M. D. K. S. M. (2023). Dyslipidemia. In Pharmacotherapy:ApathophysiologicApproach (12th ed.). McGrawHill.
Erwinanto, Sunanto Ng, Santoso Anwar, Desandri DR, Erika, Wicaksono SH, & Pintaningrum Yusra. (2022). Panduan Tata Laksana Dislipidemia. Perhimpunan Dokter Spesialis Kardiovakular Indonesia. https://www.inaheart.org/storage/guideline/7f75cffa237e402536f3d425012d985d.pdf
Insull, W., Kafonek, S., Goldner, D., & Zieve, F. (2001). Comparison of Efficacy and Safety of Atorvastatin (10 mg) With Simvastatin (10 mg) at Six Weeks on behalf of the ASSET Investigators*. The American Journal of Cardiology, 87. https://doi.org/https://doi.org/10.1016/s0002-9149(00)01430-2
kastelein John, Isaacsohn Jonathan, Ose Leiv, Habib Rafiq, Dujovne Carlos, Liu Minzhi, Hunninghake Donald, Frohlich Jiri, Davidson Michael, & Melino Michael. (2000). Comparison of Effects of Simvastatin Versus Atorvastatin on High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels. The American Of Cardiology, 85. https://doi.org/https://doi.org/10.1016/s0002-9149(00)00942-5
Kemenkes RI. (2017). Profil Penyakit Tidak Menular 2016.
MenKes RI. (2023). Keputusan Menteri Kesehatan RI Nomor HK.01.07/MENKES/2197/2023 Tentang Formularium Nasional. https://farmalkes.kemkes.go.id/unduh/kepmenkes-2197-2023/
Pakaya, R., Deisi Badu, F., & Irmawati Maliki, L. (2020). Hubungan Aktivitas Fisik Dan Pola Konsumsi Terhadap Insiden Obesitas Sentral Pada Supir Angkot. Jurnal Olahraga & Kesehatan Indonesia, 1(1), 68–74. https://jurnal.stokbinaguna.ac.id/index.php/jok
Parks, E. J. (2001). Symposium: Carbohydrates-Friend or Foe Effect of Dietary Carbohydrate on Triglyceride Metabolism in Humans 1. In American Society for Nutritional Sciences. https://doi.org/10.1093/jn/131.10.2772S
Patel, N., Mittal, N., Wilkinson, M. J., & Taub, P. R. (2024). Unique features of dyslipidemia in women across a lifetime and a tailored approach to management. American Journal of Preventive Cardiology, 18. https://doi.org/10.1016/j.ajpc.2024.100666
Paulina, A., Perangin Angin, M., & Hidayaturahmah, R. (2023). Evaluasi Penggunaan Obat Kolesterol Pada Pasien Hiperlipidemia Di Instalasi Rawat Jalan Rumah Sakit Mutiara Bunda. Jurnal Farmasi Malahayati, 6, 63–75. https://ejurnalmalahayati.ac.id/index.php/farmasi/article/view/8199
PERKENI. (2019). Pedoman Pengelolaan Dislipidemia Di Indonesia (1st ed., Vol. 1). PB Perkeni. https://pbperkeni.or.id/wp-content/uploads/2021/06/Panduan-pengelolaan-dislipidemia-2019-eBook-PDF.pdf
Robert L.Talbert. (2015). Dyslipidemia. In Terry L. Schwinghammer (Ed.), Pharmacotherapy Handbook (pp. 65–75). McGraw Hill Education.
Shalileh Maryam. (2012). Nutrigenetics and Dyslipidemia. In Kelishadi Roya (Ed.), Dyslipidemia-From Prevention To Treatment (1st ed., p. 468). InTech.
Sorrentino J Matthew. (2011). Drug Therapy For Dyslipidemia. In Hyperlipidemia in Primary Care. Humana Press. http://www.springer.com/series/7633
Tariq Rayhan A, Vashisht Rishik, Sinha Ankur, & Scherback Yevgeniya. (2024, February 12). Medication Dispensing Errors and Prevention. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK519065/
Thompson, G., Dean, J., & Wilson, P. W. (2002). Dyslipidaemia in Clinical Practice (1st ed.). Martin Dunitz Ltd.
Tim RisKesDas. (2019). Laporan Riskesdas 2018 Nasional.
Ujiani Sri. (2015). Hubungan Antara Usia dan Jenis Kelamin Dengan Kadar Kolesterol Penderita Obesitas RSUD Abdul Moeloek Provinsi Lampung. Jurnal Kesehatan, 43–48. https://doi.org/https://doi.org/10.26630/jk.v6i1.24
Wahyuning SKom, S. (2021). Dasar-Dasar Statistik (Dianta Indra Ava, Ed.; 1st ed., Vol. 1). Yayasan Prima Agus Teknik.
Welty, F. K., Lewis, S. J., Friday, K. E., Cain, V. A., & Anzalone, D. A. (2016). A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study. Journal of Women’s Health, 25(1), 50–56. https://doi.org/10.1089/jwh.2015.5271
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anna Uswatun Hasanah Rochjana, Amalina Fakhriah , salsa dea ardita

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.







